These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6635769)

  • 1. Ascorbic acid and iron excretion in a thalassemic child.
    Hathirat P; Areekul S; Pleehachinda R; Tuntawiroon M
    Southeast Asian J Trop Med Public Health; 1983 Jun; 14(2):274. PubMed ID: 6635769
    [No Abstract]   [Full Text] [Related]  

  • 2. [Findings in relation to serum and urinary iron in heterozygotic beta-thalassemia].
    Lodi G; Squarzoni G; Bariani MC; Fogli B; Masotti M; Musiari A; Bariani L
    G Clin Med; 1989 Apr; 70(4):263-6. PubMed ID: 2767366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral ascorbic acid and iron excretion in thalassemic children treated with desferrioxamine-methansulfonate (Desferal).
    Hathirat P; Isarangkura P; Areekul S; Pleehachinda R; Tuntawiroon M
    Birth Defects Orig Artic Ser; 1988; 23(5B):129-33. PubMed ID: 3390535
    [No Abstract]   [Full Text] [Related]  

  • 4. Iron excretion in thalassemia after the administration of chelating agents.
    Markum AH; Iskandar W; Keng KL; Odang O
    Paediatr Indones; 1969; 9(3):89-98. PubMed ID: 4981722
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chelating therapy in beta-thalassemia].
    Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G
    Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascorbic acid enhancement of desferrioxamine-induced urinary iron excretion in thalassemia major.
    O'Brien RT
    Ann N Y Acad Sci; 1974; 232(0):221-5. PubMed ID: 4528431
    [No Abstract]   [Full Text] [Related]  

  • 7. Urine iron excretion in beta-thalassemia trait.
    Camerini G; Voghenzi A; Kalapurackal M
    Boll Soc Ital Biol Sper; 1987 Apr; 63(4):317-21. PubMed ID: 3447608
    [No Abstract]   [Full Text] [Related]  

  • 8. The correlation of transferrin saturation and ferritin in non-splenectomized thalassemic children.
    Wangruangsathit S; Hathirat P; Chuansumrit A; Pakakasama S; Hongeng S
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S74-6. PubMed ID: 10730522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascorbic acid status in thalassemia major.
    Tagliabue A; Turconi G; Allegrini M; De Stefano P; Borgna-Pignatti C; Bongo I; Dezza L; Cazzola M
    Haematologica; 1984; 69(5):542-8. PubMed ID: 6437931
    [No Abstract]   [Full Text] [Related]  

  • 10. Desferrioxamine induced urinary iron excretion in thalassemia.
    Dubey AP; Kumar S; Choudhury P; Talukdar B; Puri RK
    Indian Pediatr; 1993 Jun; 30(6):775-8. PubMed ID: 8132258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measurement of siderinuria in thalassemia major].
    Camerini G; Voghenzi A; Kalapurackal M; Menghi G
    Boll Soc Ital Biol Sper; 1986 Feb; 62(2):181-4. PubMed ID: 3718732
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of ascorbic acid on desferrioxamine-induced siderinuria].
    Bosello O; Mengoli C; Rossi G
    Fracastoro; 1971; 64(5):310-9. PubMed ID: 5151104
    [No Abstract]   [Full Text] [Related]  

  • 13. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
    Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical management of beta-thalassemia.
    Graziano J; Piomelli S
    Tex Rep Biol Med; 1980-1981; 40():355-64. PubMed ID: 7034276
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum and platelet ascorbic acid levels in patients with hemoglobinopathies].
    de Miani MS; de Giardulli MS; de Herrlein ME; de Cohen LC; Peñalver JA
    Medicina (B Aires); 1985; 45(5):559-62. PubMed ID: 3842461
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum ferritin in the follow-up of homozygotic beta-thalassemia treated with blood transfusion and iron-chelating agents].
    Esposito L; Ferrara M; Ponte G
    Pediatria (Napoli); 1981 Sep; 89(3):479-92. PubMed ID: 7346759
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thalassemic cardiopathy: serial echocardiographic evaluation].
    Bosi S; Spinolo L; Cavallini B; Guadagni C; Lama A; Santarelli R; Baccini C
    G Clin Med; 1982 Apr; 63(4):248-54. PubMed ID: 7128980
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia.
    Taher A; El Rassi F; Isma'eel H; Koussa S; Inati A; Cappellini MD
    Haematologica; 2008 Oct; 93(10):1584-6. PubMed ID: 18728025
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevated F2-isoprostanes in thalassemic patients.
    Matayatsuk C; Lee CY; Kalpravidh RW; Sirankapracha P; Wilairat P; Fucharoen S; Halliwell B
    Free Radic Biol Med; 2007 Dec; 43(12):1649-55. PubMed ID: 18037130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ascorbic acid on desferrioxamine therapy.
    Cartei G; Meani A
    Acta Vitaminol Enzymol; 1970; 24(6):209-13. PubMed ID: 5537933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.